5-Year Reintervention Risk After Prostatic Artery Embolization for BPH in U.S. Claims Data

After prostatic artery embolization (PAE) for BPH, 5-year cumulative reintervention incidence was 25.8% (95% CI 16.2-34.3) in a U.S. claims analysis of 959 men. TURP accounted for the largest share of reinterventions (9.1% at 5 years).

• 1-year reintervention: 7.5% (95% CI 5.4-9.5); 3-year: 17.1% (12.7-21.2).
• TURP-specific 5-year cumulative incidence: 9.1% (95% CI 4.92-16.86).
• No patient characteristic was significantly associated with reintervention hazard in multivariable Cox regression.

Automated summary

RadPigeon summaries are original and for information only. They are not clinical advice.